It was shown that 23.72% (n = 97/409) of patients with esophageal adenocarcinoma had somatic mutations in EPAS1. However, there are no data available regarding the mutational status of EPAS1 in ESCC in the ICGC database. Here, EPAS1 is linked to esophageal adenocarcinoma.